Shigeru Kinoshita News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Greg Kunst, CEO of Aurion Biotech, Receives Healthcare Leadership Award from Puget Sound Business Journal

Greg Kunst, CEO of Aurion Biotech, Receives Healthcare Leadership Award from Puget Sound Business Journal
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomMichele grayGreg kunstJudith mcgarryPrix galienBeth keshishianShigeru kinoshitaKyoto prefecture university of medicineHealthcare leadershipPuget sound business journalPuget soundAurion biotechProfessor shigeru kinoshitaKyoto prefecture universityFlyingl partnersFalcon vision

Aurion Biotech Named Regenerative Therapeutics Company Of The Year By BioTech Breakthrough

Aurion Biotech Named Regenerative Therapeutics Company Of The Year By BioTech Breakthrough
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomBryan vaughnPrix galienBeth keshishianGreg kunstJudith mcgarryMichele grayShigeru kinoshitaTech breakthroughProgram recognizes innovationRegenerative therapeutics company of the yearKyoto prefecture university of medicineGlobal life sciencesAnnual awards program recognizes innovationTherapeutics companyBiotech breakthrough awards

Japanese Magsaysay winner brings sight to Vietnam s poor

Hattori Tadashi finds real happiness in serving Vietnam s less fortunate, even if it means earning less money

Republic ofShigeru kinoshitaHattori tadashiCristian martini grimaldiHattori jukuTadashi hattoriOsaka universityKyoto prefectural university of medicineVietnam national institute of ophthalmologyInternational conference hallJapan international eye hospitalJapanese magsaysayRamon magsaysay awardPrefectural universityKyoto prefectural universityProfessor kinoshita

Pitch Deck: Cell-Therapy Startup Aurion Biotech Raises $120 Million

Aurion Biotech is developing a therapy that uses cells from one healthy cornea to produce up to 100 treatments.

United statesEl salvadorShigeru kinoshitaKyoto prefectural university of medicineKyoto prefectural universityNew england journalBi primeAurion biotechCell therapyPitch deckEye diseaseAndrew dunn

Cell therapy biotech Aurion gets $120M to restore vision and revamp organ donor economics

Organ donation has long been a matter of demand outstripping supply, but Aurion Biotech aims to improve the supply part of the equation with a cell therapy. Aurion’s technology turns a single donated cornea into treatments for up to 100 patients and the startup now has $120 million for clinical trials.

El salvadorShigeru kinoshitaGreg kunstCenters for diseaseKyoto prefecture university of medicineDisease controlKyoto prefecture universityNew england journalPetrichor healthcare capital managementFlyingl partnersFalcon visionVisionary venturesWeight lossMedical devicesHealthcare innovationMedcity news